✦ LIBER ✦

Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy

✍ Scribed by A.P.G. CRIJNS; E.W. DUIKER; S. De JONG; P.H.B. WILLEMSE; A.G.J. Van Der ZEE; E.G.E. De VRIES

Book ID: 109085723
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 453 KB
Volume: 16
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2006.00503.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene expression profiles in primary ovar

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy

✍ Alessandro D. Santin; Fenghuang Zhan; Stefania Bellone; Michela Palmieri; Stefan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 550 KB

## Abstract With the goal of identifying genes with a differential pattern of expression between ovarian serous papillary carcinomas (OSPCs) and normal ovarian (NOVA) epithelium and using this knowledge for the development of novel diagnostic and therapeutic markers for ovarian cancer, we used olig

D-dimer and CA 125 levels in patients wi

D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy prognostic significance for the success of anti-cancer treatment

✍ S. S. Mirshahi; E. Pujade-Lauraine; C. Soria; M. Mirshahi; J. Fretault; A. Berna 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

Mediator of DNA damage checkpoint protei

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy

✍ Akshar N. Patel; Sharad Goyal; Hao Wu; Devora Schiff; Meena S. Moran; Bruce G. H 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 409 KB